Dr Francesco Liistro (San Donato Hospital, Arezzo, IT) discusses the 9 month primary outcomes from the IN.PACT BTK Randomized Study.

The study investigates the safety and efficacy of the paclitaxel drug-eluting balloon IN.PACT 014 versus conventional percutaneous transluminal angioplasty (PTA) for the treatment of patients with chronic total occlusions in the infrapopliteal arteries.

 

Recorded remotely from Arezzo, 2021. 

 

Questions

1. What is the IN.PACT BTK Randomized Study and why was it needed?

2. What was the study design?

3. What were your findings?

4. What conclusions can be made as a result of this study?

5. How should this trial impact practice moving forward?

6. In light of the results what is your take on the paclitaxel device controversy?

7.  What are the next steps?

 

Editor: Mirjam Boros

Recording Editor: Natascha Wienand